LEXICON PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": -171750000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | LEXICON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:29:53.852066+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/408f5d1f-a1ae-4ef3-89f4-2f2a9f8e0945
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001062822-24-000008Retrieved: 2026-08-19T10:29:53.852066+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001062822/operating-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/408f5d1f-a1ae-4ef3-89f4-2f2a9f8e0945
History
- no predecessors — first report